From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary

From Google Scholar & other sources: Selected Journal Articles, Newsletters, Dissertations, Theses, Commentary

Pediatric Quality & Safety
September 19, 2018
Improving Human Papilloma Virus Vaccination Rates at an Urban Pediatric Primary Care Center
N Brodie, KE McPeak –
Despite compelling evidence regarding its safety and efficacy, human papilloma virus vaccination rates remain low nationally with high rates of missed vaccination opportunities. Provider recommendation is the most important factor in determining vaccine approval by families; yet, studies show that providers are hesitant to strongly recommend vaccination, especially at younger ages. We hypothesized that educational and quality improvement interventions targeting our clinical team would decrease rates of missed opportunities to vaccinate patients aged 11–13 years and improve vaccination rates among patients aged 9–10 years old.

Frontiers in Medicine
doi: 10.3389/fmed.2018.00297
Review ARTICLE
Dealing with uncertainty in vaccine development: the malaria case
M Roestenberg, I Kamerling, SJ de Visser –
[Initial text]
Vaccines can be extremely cost-effective public health measures. Unfortunately the research and development (R&D) of novel vaccines is suffering from rising costs and declining success rates. Because many vaccines target low- and middle income markets (LMIC), output needs to be maintained at a constrained budget. In addition, scientific neglect and political uncertainty around reimbursement decisions make it an unattractive arena for private investors. The vaccine development pipeline for LMIC thus is in need for a different, sustainable and cost-effective development model…